B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Orantinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Orantinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

k
25 shared targets
pf
22 shared targets
azd
18 shared targets
ilorasertib
9 shared targets
cyc
22 shared targets
pf
20 shared targets
barasertib
8 shared targets
pacritinib
12 shared targets
semaxanib
7 shared targets
defosbarasertib
15 shared targets
Loading evidence profile...

This evidence profile for Orantinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.